Skip to menu Skip to content Skip to footer

2006

Journal Article

Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria

Block, J. K., Vandemheen, K. L., Tullis, E., Fergusson, D., Doucette, S., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Bye, P., Bell, S., Noseworthy, M., Pedder, L., Freitag, A. and Paterson, N. (2006). Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax, 61 (11), 969-974. doi: 10.1136/thx.2006.061366

Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria

2006

Conference Publication

A D-optimal designed population pharmacokinetic study of itraconazole

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Charles, B G and Duffull, S B (2006). A D-optimal designed population pharmacokinetic study of itraconazole. APSA Annual Meeting 2006, Adelaide, Australia, 2-5 December 2006. Adelaide:

A D-optimal designed population pharmacokinetic study of itraconazole

2006

Conference Publication

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health.

Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients

2006

Conference Publication

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

Hennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE.

A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis

2006

Journal Article

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

Hennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004

Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients

2005

Journal Article

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

Hill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005

Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions

2005

Journal Article

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014

MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?

2005

Journal Article

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

Buntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x

Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis

2005

Journal Article

Has the time come to prescribe azithromycin in cystic fibrosis patients?

McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x

Has the time come to prescribe azithromycin in cystic fibrosis patients?

2005

Conference Publication

Detection of an integron associated aadB resistance gene in Pseudomonas aeruginosa isolates from patients with CF

Syrmis, M., O'Carroll, M., Iredell, J., Wainwright, C., Coulter, C., Sloots, T., Bell, S. and Nissen, M. (2005). Detection of an integron associated aadB resistance gene in Pseudomonas aeruginosa isolates from patients with CF. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Detection of an integron associated aadB resistance gene in Pseudomonas aeruginosa isolates from patients with CF

2005

Conference Publication

Epidemic strain Burkholderia cepacia organisms in Australia

Kidd, T. A., Douglas, J., Bergh, H., Bautista, C., Coulter, C. and Bell, S. C. (2005). Epidemic strain Burkholderia cepacia organisms in Australia. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier.

Epidemic strain Burkholderia cepacia organisms in Australia

2005

Journal Article

Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis

Sweetser, Lisel J., Douglas, James A., Riha, Renata L. and Bell, Scott C. (2005). Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis. Respirology, 10 (2), 254-256. doi: 10.1111/j.1440-1843.2005.00650.x

Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis

2005

Book Chapter

Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis. Evidence-based Respiratory Medicine. (pp. 389-414) edited by P. Gibson. Carlton South, Australia: Blackwell Publishing Asia. doi: 10.1002/9780470987377.ch30

Antiobiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis

2005

Conference Publication

Multi-resistant Pseudomonas aeruginosa in an adult CF unit

Downey, D. G., Masel, P. J. and Bell, S. C. (2005). Multi-resistant Pseudomonas aeruginosa in an adult CF unit. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Multi-resistant Pseudomonas aeruginosa in an adult CF unit

2005

Conference Publication

Antibiotics for acute exacerbations of COPD: A systematic review

Yang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Antibiotics for acute exacerbations of COPD: A systematic review

2005

Conference Publication

The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates

Semple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates

2005

Conference Publication

A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update

Burrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia:

A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update

2005

Conference Publication

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

Kim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1

Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype

2005

Conference Publication

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

Kermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(05)80113-4

Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis

2005

Journal Article

Macrolides in cystic fibrosis

Bell, S. C., Senini, S. L. and McCormack, J. G. (2005). Macrolides in cystic fibrosis. Chronic Respiratory Disease, 2 (2), 85-98. doi: 10.1191/1479972305cd066rs

Macrolides in cystic fibrosis